Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.9.5237

Are Neutrophil/Lymphocyte and Platelet/Lymphocyte Rates in Patients with Non-Small Cell Lung Cancer Associated with Treatment Response and Prognosis?  

Unal, Dilek (Department of Radiation Oncology, Kayseri Education and Research Hospital)
Eroglu, Celalettin (Department of Radiation Oncology, Erciyes University Medical School)
Kurtul, Neslihan (Department of Radiation Oncology, Erciyes University Medical School)
Oguz, Arzu (Department of Medical Oncology, Kayseri Education and Research Hospital)
Tasdemir, Arzu (Department of Pathology, Kayseri Education and Research Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.9, 2013 , pp. 5237-5242 More about this Journal
Abstract
Background: Inflammation is a critical component of tumor progression. Many cancers arise from sites of infection, chronic irritation, and inflammation. It is now becoming clear that the tumour microenvironment, which is largely orchestrated by inflammatory cells, is an essential participant in the neoplastic process, promoting proliferation, survival and migration. Platelets can release some growth factors such as platelet-derived growth factor, platelet factor 4, and thrombospondin. Such factors have been shown to promote hematogenous tumour spread, tumor cell adhesion and invasion, and angiogenesis and to play an important role in tumor progression. In this study, we aimed to investigate effects of the pretreatment neutrophil to lymphocyte ratio (NLR) and the platelet to lymphocyte ratio (PLR) on survival and response to chemoradiotherapy in patients with non-small-cell lung cancer (NSCLC). Materials and Methods: Ninety-four patients with non-metastatic NSCLC were included and separated into two groups according to median valuse of NLR and PLR (low:<3.44 or high:${\geq}3.44$ and low:<194 or high${\geq}194$, respectively). Results: Pretreatment high NLR and PLR were associated with significantly shorter disease-free and overall survival rates. Multivariate analysis revealed that the overall survival rates were significantly linked with PLR (OR: 1.87, CI: 1.20-2.91, p: 0.006) and response to chemoradiotherapy (OR: 1.80, CI: 1.14-2.81, p: 0.012) and the disease-free survival rates were significantly associated with NLR (OR: 1.81, CI: 1.16-2.82, p: 0.009) and response to chemoradiotherapy (OR: 2.30, CI: 1.45-3.66, p: 0.001). There was no significant difference between patients with high and low NLR in terms of response to chemoradiotherapy. Similarly, there was no significant influence of the PLR. Conclusions: Pretreatment NLR and PLR measurements can provide important prognostic results in patients with NSCLC and assessment of the two parameters together appears to better predict the prognosis in patients with NSCLC. The effect of inflammation, indicators of NLR and PLR, on survival seems independent of the response to chemoradiotherapy.
Keywords
Neutrophil to lymphocyte ratio; non-small-cell lung cancer; platelet to lymphocyte ratio; prognosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Wang S, Zhang Z, Fang F, et al (2011). The neutrophil/ lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis. Oncol Lett, 2, 735-40.   DOI
2 Yao Y, Yuan D, Liu H, Gu X, Song Y (2013). Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy. Cancer Immunol Immunother, 62, 471-9.   DOI   ScienceOn
3 Zhang J, Huang SH, Li H, et al (2013). Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer. Med Oncol, 30, 352.   DOI   ScienceOn
4 Asher V, Lee J, Innamaa A, Bali A (2011). Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol, 13, 499-503.   DOI
5 Coussens LM, Werb Z (2002). Inflammation and cancer. Nature, 420, 860-7.   DOI   ScienceOn
6 Assoian RK, Sporn MB (1986). Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol, 102, 1217-23.   DOI
7 Cedres S, Torrejon D, Martinez A, et al (2012). Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol, 14, 864-9.   DOI   ScienceOn
8 Chua W, Charles KA, Baracos VE, Clarke SJ (2011). Neutrophil/ lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer, 104, 1288-95.   DOI   ScienceOn
9 Divella R, Daniele A, Savino E, et al (2013). Circulating levels of transforming growth factor-$\beta$ (TGF-$\beta$) and chemokine (C-X-C Motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer. Anticancer Res, 33, 1491-7.
10 Donskov F (2013). Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin Cancer Biol, 23, 200-7.   DOI   ScienceOn
11 Dubernard V, Arbeille BB, Lemesle MB, Legrand C (1997). Evidence for an alpha-granular pool of the cytoskeletal protein alpha-actinin in human platelets that redistributes with the adhesive glycoprotein thrombospondin-1 during the exocytotic process. Arterioscler Thromb Vasc Biol, 17, 2293-305.   DOI   ScienceOn
12 Kaplan KL, Broekman MJ, Chernoff A, Lesznik GR, Drillings M (1979). Platelet alpha-granule proteins: studies on release and subcellular localization. Blood, 53, 604-18.
13 Kaya MG, Akpek M, Lam YY, et al (2013). Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: A prospective, multicenter study. Int J Cardiol, 15, 1557-4.
14 Negrier S, Escudier B, Gomez F, et al (2002). Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d'Immunotherapie. Ann Oncol, 13, 1460-8.   DOI   ScienceOn
15 Kobayashi N, Usui S, Kikuchi S, et al (2012). Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer. Lung Cancer, 75, 223-7.   DOI   ScienceOn
16 Kocyigit I, Eroglu E, Unal A, et al (2013). Role of neutrophil/ lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease. J Nephrol, 26, 358-65.   DOI   ScienceOn
17 Majeti BK, Lee JH, Simmons BH, Shojaei F (2013). VEGF is an important mediator of tumor angiogenesis in malignant lesions in a genetically engineered mouse model of lung adenocarcinoma. BMC Cancer, 13, 213.   DOI   ScienceOn
18 Paesmans M, Sculier JP, Libert P, et al (1995). Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. J Clin Oncol, 13, 1221-30.   DOI
19 Qian X, Tuszynski GP (1996). Expression of thrombospondin-1 in cancer: a role in tumor progression. Proc Soc Exp Biol Med, 212, 199-207.   DOI
20 Raungkaewmanee S, Tangjitgamol S, Manusirivithaya S, Srijaipracharoen S, Thavaramara T (2012). Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. J Gynecol Oncol, 23, 265-73.   DOI   ScienceOn
21 Schmidt H, Bastholt L, Geertsen P, et al (2005). Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer, 93, 273-8.   DOI   ScienceOn
22 Stone RL, Nick AM, McNeish IA, et al (2012). Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med, 366, 610-8.   DOI   ScienceOn
23 Teramukai S, Kitano T, Kishida Y, et al (2009). Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer, 45, 1950-8.   DOI   ScienceOn
24 Tomita M, Shimizu T, Ayabe T, Nakamura K, Onitsuka T (2012). Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer. Anticancer Res, 32, 3535-8.
25 Wang D, Yang JX, Cao DY, et al (2013). Preoperative neutrophillymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma. Onco Targets Ther, 6, 211-6.